Distribution of COPD-related symptoms in the Middle East and North Africa: Results of the BREATHE study

被引:94
|
作者
Tageldin, Mohamed Awad [1 ]
Nafti, Salim [2 ]
Khan, Javaid Ahmed [3 ]
Nejjari, Chakib [4 ]
Beji, Majed [5 ]
Mahboub, Bassam [6 ]
Obeidat, Nathir M. [7 ]
Uzaslan, Esra [8 ]
Sayiner, Abdullah [9 ]
Wali, Siraj [10 ]
Rashid, Nauman [11 ]
El Hasnaoui, Abdelkader [11 ]
机构
[1] Ain Shams Univ, Cairo, Egypt
[2] Mustapha Bacha Hosp, Algiers, Algeria
[3] Aga Khan Univ Hosp, Karachi, Pakistan
[4] Fac Med Fez, Fes, Morocco
[5] Univ Tunis El Manar, La Rabta Hosp, Fac Med Tunis, Tunis, Tunisia
[6] Univ Sharjah, Sharjah, U Arab Emirates
[7] Univ Jordan, Amman, Jordan
[8] Uludag Univ, Fac Med, Bursa, Turkey
[9] Ege Univ, Izmir, Turkey
[10] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia
[11] GlaxoSmithKline, Dubai, U Arab Emirates
关键词
COPD; Symptoms; Middle East; North Africa; BREATHE study; Prevalence; Chronic bronchitis; Smoking; OBSTRUCTIVE PULMONARY-DISEASE; CHRONIC-BRONCHITIS; LUNG-DISEASE; BURDEN; PREVENTION; PREVALENCE; MANAGEMENT; COUNTRIES; IMPACT;
D O I
10.1016/S0954-6111(12)70012-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide. However, its epidemiology in many developing countries is poorly characterised. The objective of this analysis was to evaluate respiratory symptoms which could be COPD-related in a large sample of individuals aged 40 years in ten countries in the Middle East and North Africa (Algeria, Egypt, Jordan, Lebanon, Morocco, Saudi Arabia, Syria, Tunisia, Turkey and United Arab Emirates), together with Pakistan, using a standardised methodology. A random sample of 457,258 telephone numbers was contacted. A screening questionnaire was administered to each eligible participant, which included six questions relating to respiratory symptoms. Of 65,154 eligible subjects, 62,086 agreed to participate and 61,551 provided usable data. The age- and gender-adjusted prevalence of symptoms (persistent productive cough or breathlessness or both) was 14.3% [95% CI: 14.0-14.6%], ranging from 7.2% in UAE to 19.1% in Algeria. Symptoms were more frequent (p < 0.0001) in women (16.7%) than in men (12.2%). The adjusted prevalence of COPD according to the "epidemiological" definition (symptoms or diagnosis and cigarette use >= 10 pack-years) was 3.6% [95% CI: 3.5-3.7%] (range: 1.9% in UAE to 6.1% in Syria). COPD was more frequent (p < 0.0001) in men (5.2%) than in women (1.8%). The frequency of symptoms was significantly higher in cigarette smokers (p < 0.001), as well as in waterpipe users (p < 0.026). In conclusion, the prevalence of COPD in this region seems to be lower than that reported in industrialised countries. Under-reporting and risk factors other than smoking may contribute to this difference. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:S25 / S32
页数:8
相关论文
共 50 条
  • [1] Epidemiology, management and burden of COPD in the Middle East and North Africa: the BREATHE study
    Hanania, Nicola A.
    RESPIRATORY MEDICINE, 2012, 106 : S1 - S2
  • [2] Smoking habits in the Middle East and North Africa: Results of the BREATHE study
    Khattab, Adel
    Javaid, Arshad
    Iraqi, Ghali
    Alzaabi, Ashraf
    Ben Kheder, Ali
    Koniski, Marie-Louise
    Shahrour, Naem
    Taright, Samya
    Idrees, Magdy
    Polatli, Mehmet
    Rashid, Nauman
    El Hasnaoui, Abdelkader
    RESPIRATORY MEDICINE, 2012, 106 : S16 - S24
  • [3] Distribution of body mass index among subjects with COPD in the Middle East and North Africa region: data from the BREATHE study
    Koniski, Marie-Louise
    Salhi, Hocine
    Lahlou, Aicha
    Rashid, Nauman
    El Hasnaoui, Abdelkader
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 1685 - 1694
  • [4] Management of chronic obstructive pulmonary disease in the Middle East and North Africa: Results of the BREATHE study
    Idrees, Majdy
    Koniski, Marie-Louise
    Taright, Samya
    Shahrour, Naeem
    Polatli, Mehmet
    Ben Kheder, Ali
    Alzaabi, Ashraf
    Iraqi, Ghali
    Khattab, Adel
    Javed, Arshad
    Rashid, Nauman
    El Hasnaoui, Abdelkader
    RESPIRATORY MEDICINE, 2012, 106 : S33 - S44
  • [5] The burden of chronic obstructive pulmonary disease in the Middle East and North Africa: Results of the BREATHE study
    Uzaslan, Esra
    Mahboub, Bassam
    Beji, Majed
    Nejjari, Chakib
    Tageldin, Mohamed Awad
    Khan, Javaid Ahmed
    Nafti, Salim
    Obeidat, Nathir M.
    Sayiner, Abdullah
    Wali, Siraj
    Rashid, Nauman
    El Hasnaoui, Abdelkader
    RESPIRATORY MEDICINE, 2012, 106 : S45 - S59
  • [6] Psychometric evaluation of the COPD assessment test: Data from the BREATHE study in the Middle East and North Africa region
    Jones, Paul W.
    Shahrour, Naem
    Nejjari, Chakib
    Lahlou, Aicha
    Doble, Adam
    Rashid, Nauman
    El Hasnaoui, Abdelkader
    RESPIRATORY MEDICINE, 2012, 106 : S86 - S99
  • [7] Waterpipe Use in the Middle East and North Africa: Data From the Breathe Study
    Alzaabi, Ashraf
    Mahboub, Bassam
    Salhi, Hocine
    Kajingu, Wisco
    Rashid, Nauman
    El-Hasnaoui, Abdelkader
    NICOTINE & TOBACCO RESEARCH, 2017, 19 (11) : 1375 - 1380
  • [8] Lifetime body shapes and COPD-related symptoms
    Waatevik, Marie
    Real, Francisco
    Eagan, Tomas
    Schlunssen, Vivi
    Gislason, Torarinn
    Benediktsdottir, Bryndis
    Jogi, Rein
    Omenaas, Ernst
    Janson, Christer
    Svanes, Cecilie
    Macsali, Ferenc
    Lindberg, Eva
    Johannessen, Ane
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [9] Chronic obstructive pulmonary disease and associated healthcare resource consumption in the Middle East and North Africa: The BREATHE study
    Polatli, Mehmet
    Ben Kheder, Ali
    Wali, Siraj
    Javed, Arshad
    Khattab, Adel
    Mahboub, Bassam
    Iraqi, Ghali
    Nejjari, Chakib
    Taright, Samya
    Koniski, Marie-Louise
    Rashid, Nauman
    El Hasnaoui, Abdelkader
    RESPIRATORY MEDICINE, 2012, 106 : S75 - S85
  • [10] The Middle East and North Africa
    Beeley, BW
    POLITICAL GEOGRAPHY, 1998, 17 (01) : 120 - 121